Clec14a - C-type lectin domain family 14, member a Gene
Also Known as 1200003C23Rik
Species: Mus musculus
Summary
Predicted to enable extracellular matrix binding activity and extracellular matrix protein binding activity. Involved in cell migration involved in sprouting angiogenesis. Acts upstream of or within with a positive effect on vascular endothelial growth factor receptor-3 signaling pathway. Acts upstream of or within with a negative effect on vascular endothelial growth factor receptor-2 signaling pathway. Acts upstream of or within lymphangiogenesis and sprouting angiogenesis. Located in collagen-containing extracellular matrix. Is expressed in bladder; choroid plexus; diencephalon roof plate; and embryo mesenchyme. Orthologous to human CLEC14A (C-type lectin domain containing 14A). [provided by Alliance of Genome Resources, Apr 2022]
Clec14a Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_025809.5 | NP_080085.3 | C-type lectin domain family 14 member A precursor |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in cell migration involved in sprouting angiogenesis |
IMP
IMP: Inferred from mutant phenotype
|
25745997 | MGI |
| acts upstream of or within lymphangiogenesis |
IMP
IMP: Inferred from mutant phenotype
|
27991863 | MGI |
| acts upstream of or within sprouting angiogenesis |
IMP
IMP: Inferred from mutant phenotype
|
27991863 | MGI |
| acts upstream of or within negative effect vascular endothelial growth factor receptor-2 signaling pathway |
IMP
IMP: Inferred from mutant phenotype
|
27991863 | MGI |
| acts upstream of or within positive effect vascular endothelial growth factor receptor-3 signaling pathway |
IMP
IMP: Inferred from mutant phenotype
|
27991863 | MGI |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
C-type lectin domain family 14 member A |
|
Recombinant Clec14a Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P76828 | CLEC14A Protein, Mouse (HEK293, His) | Q8VCP9 (E22-T386) | ≥ 95%, as determined by reducing SDS-PAGE. |